Clinical Trials Logo
  1. Home
  2. Drug Overdose
  3. NCT06327061

Social Network Overdose Prevention and Education Intervention

Drug Overdose Clinical Trial

Official title:
A Social Diffusion Fatal Overdose Prevention Intervention: Assessing the Effectiveness of People Who Use Opioids as Peer Educators in Training Using & Non-using Networks on Overdose & Stigma Reduction

Clinical Trial Summary

The purpose of this study is to test a social intervention focused on overdose prevention and care. In the investigators prior work, the investigators have shown that people who use opioids (PWUO) can be effective peer educators (PEs).

Clinical Trial Description

The purpose of this study is to test a social intervention focused on overdose prevention and care. In the investigators prior work, the investigators have shown that people who use opioids (PWUO) can be effective peer educators (PEs). The investigators have utilized PEs for overdose prevention in interventions that have focused on training network members who use drugs to respond to an overdose. Yet, many overdoses are witnessed by people who do not use drugs. Additionally, many PWUO report using drugs at home and living with someone who does not use drugs, which highlights the importance of training non-using network members on overdose response. Based on pilot data, the investigators propose expanding an overdose peer education intervention to focus on non-using network members. The intervention seeks to prepare network members to respond to an overdose and normalize discussions about overdose prevention planning between index PWUO and non-using network members. The intervention condition consists of 3 individual sessions focused on overdose prevention and response. This condition is designed to train index study participants to be Peer Educators. In addition to the three sessions, the non-drug using network member will be offered one session. The control condition is only 1 session focused on overdose prevention and response. Both intervention and control participants will invite social network members to take part in data collection activities ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06327061
Study type Interventional
Source Johns Hopkins Bloomberg School of Public Health
Contact Carl Latkin, PhD
Phone (410)955-3972
Email carl.latkin@jhu.edu
Status Not yet recruiting
Phase N/A
Start date June 1, 2024
Completion date December 1, 2027
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04070521 - EEG Monitoring in the Emergency Department
Completed NCT04372238 - The Rhode Island Prescription and Illicit Drug Study N/A
Withdrawn NCT04391192 - Virtual Overdose Response N/A
Completed NCT02924454 - Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol. Phase 4
Completed NCT02282306 - Phone Interview to Prevent Recurring Opioid Overdoses N/A
Not yet recruiting NCT01912573 - Nasal Naloxone for Narcotic Overdose Phase 4
Completed NCT04091659 - Use of Virtual Reality for Overdose Management Educational Trainings N/A
Recruiting NCT05517668 - Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose Phase 2
Completed NCT02572089 - Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers Phase 1
Completed NCT02152397 - Safety and Health Intervention Project N/A
Active, not recruiting NCT05096429 - Preventing Overdose Using Information and Data From the Environment N/A
Recruiting NCT03845699 - Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose
Completed NCT03840018 - Effectiveness of a Postal Intervention to Improve the Use of PPI N/A
Completed NCT03087149 - Monitored vs Standard Supplementation of Vitamin D in Preterm Infants N/A
Recruiting NCT05657106 - Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk N/A
Completed NCT02598856 - Bioavailability of Nasal Naloxone and Injected Naloxone Compared Phase 1
Completed NCT02158117 - Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use Phase 1
Recruiting NCT05146336 - CytOSorb TreatMent Of Critically Ill PatientS Registry
Not yet recruiting NCT02733822 - Buccal Versus Injectable Naloxone: a Phase I Healthy Volunteer Study Phase 1
Active, not recruiting NCT05308303 - AI to Improve Data From Danish Cardiac Arrest Registry